CONNECT WITH US
AI & Deeptech

AI & Deeptech

Anthropic is setting up a biology lab where Claude guides robots through drug experiments

The Decoder logo

Published on

Add as a preferred source on Google
Anthropic is setting up a biology lab where Claude guides robots through drug experiments

Anthropic is building its own biology lab to push AI-driven drug development beyond computer simulations. The lab, located in the San Francisco area, will allow the company to run physical experiments, Reuters reports.

The plan is for Claude to guide robots through experiments with minimal human involvement. Anthropic has already shipped two tools to make that work: Claude Science, an AI workspace built for researchers, and the Model Hardware Standard for controlling lab equipment. Human oversight is still required for safety, the company says.

Eric Kauderer-Abrams, who runs Anthropic's life sciences division, sees the biggest opportunity in diseases long considered "undruggable" because no treatment exists. AI could speed up the design of complex antibodies that hit multiple targets at once, he says.

The lab push builds on moves Anthropic made earlier this year. In April, the company acquired the startup Coefficient Bio for about $400 million and added Novartis CEO Vas Narasimhan to its board. Anthropic won't run its own clinical trials for now, according to the report, to avoid stepping on pharma companies' toes.

Subscribe to THE DECODER for ad-free reading, a weekly AI newsletter, our exclusive "AI Radar" frontier report six times a year, full archive access, and access to our comment section.



Source link
Related Topics:AI & Deeptech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.